UNH
$375.98-0.09%
as of close, Oct 7, 2026
☾ AH $375.98 -0.09%
UnitedHealth Group Incorporated Common Stock (DE)Stock · HealthcareDow Jones 4.7%S&P 500 0.6%Russell 1000 0.5%US Stock Market 0.5%Russell 3000 0.5%MSCI World 0.4%MSCI ACWI 0.4%S&P 500 Equal Weight 0.2%
UNH — UnitedHealth Group Incorporated Common Stock (DE) price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED
150.0200.0250.0300.0350.0400.0450.0500.0550.0600.00200.0M$375.98—20162019202120242026
2026-10-07
Price$375.98
MA20$394.21
MA50$347.64
Vol19.8M
Key stats#
Price data
- Price
- $375.98
- YTD price return
- +13.90%
- YTD total return
- +16.15%
- Next earnings
- Oct 13, 2026 · Before open
- Market cap
- 337.5B
- Enterprise value
- 390B
- Shares outstanding
- 897.6M
- 52W low
- $255.97
- 52W high
- $461.62
- From 52W high
- -18.55%
- From 52W low
- +46.88%
- 52W range
- 58%
- Beta
- 0.62
Volume
- Rel volume
- 1.15×
- 30D volume
- 4.9M
- 30D $ vol
- 1.9B
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$661K
- Insider net 1Y
- −$945K
Form 4 transactions by trade date, as filed; latest on file 2026-08-21.
Fundamentals
- Sales (ttm)
- 450.1B
- Sales/share
- $501.48
- EPS (ttm)
- $15.55
- FCF (ttm)
- 23.6B
- FCF/share
- $26.31
- Book value/share
- $116.44
- Net margin
- 3.14%
- ROE
- 13.51%
- ROA
- 4.56%
- Debt / equity
- 0.66×
- Current ratio
- 0.78
Growth (CAGR, ttm) · 10Y
- Sales
- +6.46%+8.90%+10.59%+9.84%
- Net income
- -33.71%-12.54%-0.54%+8.62%
- FCF
- -6.55%-14.80%+4.99%+10.56%
- Shares
- -0.89%-1.04%-0.98%-0.59%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -32.76%-11.38%+0.55%+9.30%
- Sales/share
- +7.42%+10.05%+11.69%+10.49%
- FCF/share
- -5.71%-13.91%+6.03%+11.22%
- Book value/share
- +4.96%+7.27%+8.80%+11.82%
- Dividend/share
- +5.17%+9.43%+11.47%+15.47%
- Price
- +3.39%-10.51%-1.46%+10.66%
- Total return
- +6.15%-8.62%+0.34%+12.52%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 24.2×
- P/OI (ttm)
- 15.6×
- Fwd P/E
- 16.7×
- P/S (ttm)
- 0.7×
- P/B (mrq)
- 3.2×
- P/FCF (ttm)
- 14.3×
- EV/EBITDA (fy)
- 15.0×
- EV/Sales (ttm)
- 0.9×
- FCF yield (ttm)
- 7.00%
- Dividend yield (fwd)
- 2.47%
- Dividend yield (ttm)
- 2.41%
- Dividend/share (fwd)
- $9.28
- Buyback yield (realized, 1y)
- 0.89%
- Shareholder yield (realized, 1y)
- 3.76%
- Buyback yield (cash, ttm)
- 0.31%
- Shareholder yield (cash, ttm)
- 2.71%
Vs own 10Y history
- P/E
- 69th
- P/OI
- 69th
- P/S
- 10th
- P/B
- 10th
- P/FCF
- 16th
Bar = where today’s multiple sits in UNH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-07#
1D
-0.09%
5D
+2.42%
1M
-5.33%
3M
-12.19%
YTD
+13.90%
1Y
+3.39%
5Y
-7.10%
Recent filings#
All filings and insider trades →Financial statements
Open full UNH financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +3.42% | +2.70% |
| JNJ | Johnson & Johnson | -6.10% | +1.44% |
| ABBV | AbbVie Inc. | +5.81% | +1.75% |
| MRK | Merck & Co. Inc. | -5.02% | +0.60% |
| TMO | Thermo Fisher Scientific Inc. | +7.87% | +0.83% |
| AMGN | Amgen Inc. | -5.52% | +2.60% |
| GILD | Gilead Sciences Inc. | -2.75% | +1.82% |
| ABT | Abbott Laboratories | -8.86% | +0.58% |
